首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1672906

經皮貼片市場按類型、應用、分銷管道和地區分類

Transdermal Skin Patches Market, By Type, By Application, By Distribution Channel, By Geography

出版日期: 2025年02月20日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球經皮貼片市場規模估計為 92.9 億美元，預計到 2032 年將達到 137.1 億美元，2025 年至 2032 年的複合年成長率為 5.7%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	92.9 億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025 年至 2032 年複合年成長率	5.70%	2032 年金額預測	137.1億美元

數字。 2025 年經皮貼片市場佔有率（按地區分類）

由於全球各種慢性病的發生率不斷上升，過去幾年全球經皮貼劑市場發展勢頭強勁。經皮貼片提供了一種便捷的藥物傳遞方式，與傳統藥物傳遞方法相比具有多種優點。這些貼片能夠以預定的速率和預定的時間段透過皮膚將藥物輸送到血液中。它可最大限度地減少口服時對胃部的刺激，並可在較長時間內釋放藥物。此外，經皮貼片可提供非侵入性和無痛的藥物輸送，進而提高患者的治療順從性。老年人口的增加、自我用藥需求的增加以及對便利藥物輸送系統的需求不斷成長，是預計未來幾年推動經皮貼片需求的主要因素。

市場動態

心血管疾病、糖尿病、慢性疼痛、癌症和神經病變等慢性疾病的發生率不斷上升是推動全球採用經皮貼片的主要因素。此外，老年人口的增加也推動了市場的發展，老年人更容易罹患慢性病。由於非侵入性、無針藥物輸送系統方便且易於使用，患者和看護者對其的偏好增加，這進一步推動了對經皮貼片的需求。然而，經皮貼片給藥系統的高開發成本以及臨床測試相關的監管挑戰是預測期內預計會在一定程度上抑制市場成長的一些因素。然而，配方技術的進步使得藥物輸送速度更快、範圍更廣。這有望為市場參與企業提供豐厚的成長機會。

研究的主要特點

本報告對全球經皮貼片市場進行了詳細分析，並給出了預測期（2025-2032）的市場規模（十億美元）和年複合成長率（CAGR%），假設 2024 年為基準年。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
報告根據以下參數概述了全球經皮貼片市場的主要企業—公司亮點、產品系列、關鍵亮點、財務表現和策略。
主要企業包括諾華公司、普渡製藥有限公司、Viatris 公司、帝國製藥美國公司、強生服務公司、梯瓦製藥工業有限公司、綠葉製藥股份有限公司、三養株式會社、Vektor Pharma、久光製藥株式會社、UCB SA、Hikma Pharmaceuticals PLC、Coriium 公司、日東株式會社、Apixco區Pharma。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球經皮貼劑市場迎合了該行業的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過全球經皮貼片市場分析中使用的各種策略矩陣來促進決策。

公司簡介
- Novartis AG
- Purdue Pharma LP
- Viatris, Inc.
- Teikoku Pharma USA, Inc.
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- LUYE PHARMA AG
- Samyang Holdings Corporation
- Vektor Pharma
- Hisamitsu Pharmaceutical Co., Inc.
- UCB SA
- Hikma Pharmaceuticals PLC
- Corium, Inc.
- Nitto Denko Corporation
- Gedeon Richter Plc.
- Agile Therapeutics
- Amneal Pharmaceuticals LLC.
- Cipla
- AdhexPharma

第 10 章分析師觀點

興衰
一致的機會地圖

第 11 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI5085

Global Transdermal Skin Patches Market is estimated to be valued at USD 9.29 Bn in 2025 and is expected to reach USD 13.71 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 9.29 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.70%	2032 Value Projection:	USD 13.71 Bn

Figure. Transdermal Skin Patches Market Share (%), By Region 2025

The global transdermal skin patches market has been gaining traction over the past few years owing to the growing prevalence of various chronic diseases globally. Transdermal skin patches provide a convenient mode of delivery of drugs and offer several advantages over conventional drug delivery methods. These patches administer medication through the skin and into the bloodstream at a predetermined rate for an intended duration. They minimize gastric irritation caused by oral administration of drugs and provide controlled release of drug for an extended period of time. Moreover, transdermal skin patches offer non-invasive and painless delivery of drugs, which enhances patient compliance in therapy. Rising geriatric population, increasing demand for self-administration of drugs, and growing need for convenient drug delivery systems are some of the key factors anticipated to fuel the demand for transdermal skin patches in the coming years.

Market Dynamics:

Growing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, chronic pain, cancer, and neurological disorders, is a key factor boosting the adoption of transdermal skin patches globally. Moreover, the rising geriatric population who are more prone to develop chronic conditions is also augmenting the market growth. The growing preference of patients and care-givers for non-invasive and needle-free drug delivery systems owing to convenience and ease-of-use is further propelling the demand for transdermal skin patches. On the other hand, high development costs associated with transdermal patch-based drug delivery systems and regulatory challenges pertaining to clinical trials are some of the factors expected to restrain the market growth to a certain extent over the forecast period. However, ongoing advancements in formulation technologies are aimed at enhancing delivery rates of a wider range of drugs. This is expected to offer lucrative growth opportunities for players in this market.

Key Features of the Study:

This report provides an in-depth analysis of the global transdermal skin patches market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global transdermal skin patches market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Novartis AG, Purdue Pharma L.P., Viatris, Inc., Teikoku Pharma USA, Inc., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., LUYE PHARMA AG, Samyang Holdings Corporation, Vektor Pharma, Hisamitsu Pharmaceutical Co.,Inc., UCB S.A., Hikma Pharmaceuticals PLC , Corium, Inc., Nitto Denko Corporation, Gedeon Richter Plc., Agile Therapeutics, Amneal Pharmaceuticals LLC., Cipla, and AdhexPharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global transdermal skin patches market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transdermal skin patches market.

Detailed Segmentation-

By Type:
- Single-layer Drug-in-Adhesive
- Multi-layer Drug-in-Adhesive
- Matrix
- Others
By Application:
- Pain Relief
- Smoking Cessation
- Overactive Bladder
- Hormonal Therapy
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Novartis AG
- Purdue Pharma L.P.
- Viatris, Inc.
- Teikoku Pharma USA, Inc.
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- LUYE PHARMA AG
- Samyang Holdings Corporation
- Vektor Pharma
- Hisamitsu Pharmaceutical Co., Inc.
- UCB S.A.
- Hikma Pharmaceuticals PLC
- Corium, Inc.
- Nitto Denko Corporation
- Gedeon Richter Plc.
- Agile Therapeutics
- Amneal Pharmaceuticals LLC.
- Cipla
- AdhexPharma

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Transdermal Skin Patches Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Transdermal Skin Patches Market, By Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Single-layer Drug-in-Adhesive
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Multi-layer Drug-in-Adhesive
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Matrix
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Transdermal Skin Patches Market, By Application, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Pain Relief
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Smoking Cessation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Overactive Bladder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hormonal Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Transdermal Skin Patches Market, By Distribution Channel, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Transdermal Skin Patches Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Purdue Pharma L.P.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Viatris, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teikoku Pharma USA, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Johnson & Johnson Services, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- LUYE PHARMA AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Samyang Holdings Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Vektor Pharma
- Hisamitsu Pharmaceutical Co., Inc.
- UCB S.A.
- Hikma Pharmaceuticals PLC
- Corium, Inc.
- Nitto Denko Corporation
- Gedeon Richter Plc.
- Agile Therapeutics
- Amneal Pharmaceuticals LLC.
- Cipla
- AdhexPharma